kabutan
N225

65,606.71

-0.12%

TOPIX

4,074.93

+0.47%

USDJPY

158.35

-0.08%

Kringle Pharma, Net Income Forecast for the Fiscal Year Loss to Narrow

Wed Jul 16, 2025 4:15 pm JST Revision

4884 Kringle Pharma,Inc. 【J-GAAP】

Guidance Update Report

Kringle Pharma,Inc. <4884> [TSE Growth] announced a performance revision after the market closed on July 16th (16:15). The net income/loss (non-consolidated) forecast for the fiscal year ending September 2025 has been revised upward from an expected loss of 1.38 billion yen to a loss of 0.94 billion yen (compared to a loss of 0.75 billion yen in the previous period), indicating a reduction in the loss margin.

Based on the upwardly revised full-year plan announced by the company, our calculation indicates that the April to September period (second half) net income/loss has been revised upward from an expected loss of 0.86 billion yen to a loss of 0.43 billion yen (compared to a loss of 0.39 billion yen in the same period of the previous year), indicating a reduction in the loss margin.

Kabutan News

Guidance Update

Second Half Update
Fiscal Year Revenue Operating
Profit
Ordinary
Profit
Net
Profit
Adj.
EPS
Adj.
Dividend
Announce Accounting
Standards
Apr - Sep, 2025 Prev 237M -868M -868M -868M -124.0 0 May 12, 2025 J-GAAP
Apr - Sep, 2025 New 36M -428M -434M -434M -62.0 0 Jul 16, 2025 J-GAAP
Revision Rate -84.8% +50.7% +50.0% +50.0% +50.0%
Full Year Update
Fiscal Year Revenue Operating
Profit
Ordinary
Profit
Net
Profit
Adj.
EPS
Adj.
Dividend
Announce Accounting
Standards
Sep, 2025 Prev 272M -1,379M -1,379M -1,380M -197.2 0 Nov 13, 2024 J-GAAP
Sep, 2025 New 71M -939M -945M -946M -135.2 0 Jul 16, 2025 J-GAAP
Revision Rate -73.9% +31.9% +31.5% +31.4% +31.5%

Current Period Guidance

Second Half Results
Fiscal Year Revenue Operating
Profit
Ordinary
Profit
Net
Profit
Adj.
EPS
Adj.
Dividend
Announce Accounting
Standards
Apr - Sep, 2024
37M -451M -389M -390M -61.0 0 Nov 13, 2024 J-GAAP
Guidance
Apr - Sep, 2025
36M -428M -434M -434M -62.0 0 Jul 16, 2025 J-GAAP
YoY -2.7% +5.1% -11.6% -11.3% -1.7%
Current Period Guidance
Fiscal Year Revenue Operating
Profit
Ordinary
Profit
Net
Profit
Adj.
EPS
Adj.
Dividend
Announce Accounting
Standards
Sep, 2023
69M -888M -852M -854M -158.5 0 Nov 13, 2023 J-GAAP
Sep, 2024
80M -817M -754M -756M -118.2 0 Nov 13, 2024 J-GAAP
Guidance
Sep, 2025
71M -939M -945M -946M -135.2 0 Jul 16, 2025 J-GAAP
YoY -11.3% -14.9% -25.3% -25.1% -14.3%